GLOBAL IMMUNOFLUORESCENCE QUANTITATIVE ANALYZER MARKET 

INTRODUCTION

 Immunofluorescence (IF) is an important immunochemical technique that allows detection and localization of a wide variety of antigens in different types of tissues of various cell preparations. There are two classes of immunofluorescence techniques, primary (or direct) and secondary (or indirect).

Immunofluorescence can be used on tissue sections, cultured cell lines, or individual cells, and may be used to analyse the distribution of proteins, glycans, and small biological and non-biological molecules. This technique can even be used to visualise structures such as intermediate-sized filaments.

Immunofluorescence assay (IFA) is a standard virologic technique to identify the presence of antibodies by their specific ability to react with viral antigens expressed in infected cells; bound antibodies are visualised by incubation with fluorescently labelled anti human antibody.

The principle behind the Immunoassay test is the use of an antibody that will specifically bind to the antigen of interest. The antibodies used in the Immunoassay must have a high affinity for the antigen. The antibodies used in the Immunoassay can either be monoclonal or polyclonal antibodies.

GLOBAL IMMUNOFLUORESCENCE QUANTITATIVE ANALYZER MARKET SIZE AND FORECAST

Global immunofluorescence quantitative analyzer market accounted for $XX Billion in 2022 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2023 to 2030.

NEW PRODUCT LAUNCH

Getein 1600 Immunofluorescence Quantitative Analyzer.Getein 1600 Immunofluorescence Quantitative Analyzer (hereinafter called Getein 1600) is a fully-automatic bench-top diagnostic analyzer. Combined together with bar-coded, ready-to-use strip cassettes, Getein 1600 is designed to deliver accurate testing results in minutes.

In conjunction with dedicated test kits of Immunofluorescence, the instrument automates the detection and quantification of markers for cardiovascular disease, renal diseases, inflammation, fertility, diabetes mellitus, bone metabolism, tumour and thyroid in a biological sample.

Features: Simple Operation, Fully-automatic detection, Real-time monitoring of samples and consumables,Visualised reagent interface, Intellectualized Software System, Android system, User-friendly interface, Diversified test modes: random, batch, STAT, LIS/HIS connectivityWIFI/4G data transmission, Network printer.

 The RaFIA Immunofluorescence Analyzer is a fluorescence immunoassay analysing instrument intended for use by healthcare professionals to aid in the diagnosis of conditions such as cardiovascular disease, pregnancy, infection, diabetes, renal injury and cancer.

COMPANY PROFILE

• Lepu
• Getein
• CTK biotech
• Omnia
• Normanbio

THIS REPORT WILL ANSWER FOLLOWING QUESTIONS

1. How many immunofluorescence quantitative analyzers are manufactured per annum globally? Who are the sub-component suppliers in different regions?
2. Cost breakup of a Global immunofluorescence quantitative analyzer and key vendor selection criteria
3. Where is the immunofluorescence quantitative analyzer manufactured? What is the average margin per unit?
4. Market share of Global immunofluorescence quantitative analyzer market manufacturers and their upcoming products
5. Cost advantage for OEMs who manufacture Global immunofluorescence quantitative analyzer in-house
6. key predictions for next 5 years in Global immunofluorescence quantitative analyzer market
7. Average B-2-B immunofluorescence quantitative analyzer market price in all segments
8. Latest trends in immunofluorescence quantitative analyzer market, by every market segment
9. The market size (both volume and value) of the immunofluorescence quantitative analyzer market in 2023-2030 and every year in between?
10. Production breakup of immunofluorescence quantitative analyzer market, by suppliers and their OEM relationship